Powder: -20°C for 3 years | In solvent: -80°C for 1 year
P8RI acetate is a biomimetic peptide of CD31 and an agonist of CDP8RI acetate shows an immunosuppressive effect through the restoration of the CD31 inhibitory pathway.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 56.00 | |
2 mg | In stock | $ 79.00 | |
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 176.00 | |
25 mg | In stock | $ 316.00 | |
50 mg | In stock | $ 476.00 | |
100 mg | In stock | $ 697.00 |
Description | P8RI acetate is a biomimetic peptide of CD31 and an agonist of CDP8RI acetate shows an immunosuppressive effect through the restoration of the CD31 inhibitory pathway. |
In vitro | P8RI acetate maintains bioactivity and confers resistance toward plasma proteases[2]. |
In vivo | In Apo E -/- mice (male, 28-week-old) implanted with Ang II-releasing pumps (a model of experimental acute aortic dissection and intramural hematoma (ADIM)), P8RI acetate (2.5 mg/kg; s.c.) prevents aneurysmal transformation by promoting the resolution of intramural hematoma and the production of collagen in dissected aortas[3]. |
Molecular Weight | 1076.29 |
Formula | C53H81N13O11 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
P8RI acetate Cytoskeletal Signaling Integrin P-8RI aceate (2147724-76-1 Free base) P8RI Acetate inhibitor inhibit